📅 Thursday, April 16, 2026
Volume normalized after Wednesday's historic $12.1B spike, but the directional message didn't change. $966.7M across 673 trades with 189 sells against 29 buys — a 6.5:1 ratio that's actually worse than Wednesday's 5:1. The de-risking isn't slowing down post-whale-day; it's accelerating in breadth. Insiders at Corning, Constellation Brands, and AST SpaceMobile all reduced exposure on the same session. The only green on the board: a surgical rotation into specialized healthcare names.
Thursday Insider Sentiment — Apr 16, 2026
6.5:1 Sell Ratio — The Week's Most Lopsided Session by Ratio
▼ 189 Sells (87%)
29 Buys (13%) ▲
Nearly 6.5 sellers for every 1 buyer
Week Sell Ratio Arc — Apr 13–16
Mon 4/13
$SMC, $HTO buys · 2.3:1 ratio — best week session
$730M
Tue 4/14
$NKE buy · $FDX exit · 6.3:1 ratio
$212M
Wed 4/15
🐋 $12.1B whale day · $LW + $CAG · 5:1 ratio
$12.1B
Thu 4/16 Today
$GLW, $STZ exits · $VANI + $BEAT buys · 6.5:1
$966M
1. The Insider Tape
Thursday Insider Tape — Apr 16, 2026
Total Volume
$966.7M
Total Trades
673
Buys
29
Sells
189
Notable Buying — Specialized Healthcare
$VANI
$BEAT
$CRT
Notable Selling — Industrial, Consumer, Space
$ASTS
$GLW
$STZ
2. The Exit Trio — $ASTS, $GLW, $STZ
$ASTS
AST SpaceMobile
Space / Satellite
Direct-to-cell satellite broadband. High-hype, pre-revenue infrastructure play. Insider exits here signal the premium on space tech optimism is compressing as rate expectations hold elevated.
$GLW
Corning Inc.
Industrial Tech
Glass and ceramic materials — optical fiber, specialty glass for displays and semiconductors. A bellwether for capex spending in data centers and consumer electronics. Insider selling suggests a pause in that capex thesis.
$STZ
Constellation Brands
Consumer Staples
Beer, wine, and spirits — Corona, Modelo, Robert Mondavi. Despite being a "defensive" consumer staples name, insider exits here suggest even traditional safe-haven staples aren't immune to the current de-risking wave.
The $ASTS Signal
Satellite Hype Meets Insider Reality
$ASTS (AST SpaceMobile) insider selling is the most speculative exit of the week. The company is building a direct-to-cell broadband satellite constellation — a genuinely ambitious infrastructure bet. But the business is pre-revenue and capital-intensive at exactly the moment when the rate environment punishes long-duration, speculative capex plays. When the people with the most visibility into the operational timeline start reducing, it's worth noting regardless of the macro thesis.
3. The Defensive Rotation — $VANI & $BEAT
Surgical Buy Cluster — Healthcare Specialists
In a 189-sell session, the only conviction is in specialized healthcare.
$VANI
Vivani Medical
Specialized Healthcare
Subdermal implant technology for chronic disease management. Niche medical device with recurring revenue once implanted. High-moat, rate-insensitive demand profile.
$BEAT
HeartBeam Inc.
Medical Technology
Cardiac monitoring technology — 3D vector electrocardiography. Diagnostics with FDA pathway. Healthcare demand doesn't compress with rate hikes — it's non-cyclical by nature.
The choice of $VANI and $BEAT as conviction buys in a 6.5:1 sell session tells a specific story: insiders who are buying right now are choosing names where customer demand is structurally non-discretionary. Whether rates are 3.5% or 5.5%, people still need cardiac monitoring and chronic disease treatment. This is the same defensive logic that drove $LW and $CAG buys Wednesday, and $NKE Tuesday — each day's buyers are seeking rate-immune revenue.
4. The Filing Desk — 33 More Audited Reports
10-K
Annual + Quarterly
33 audited reports today
25 annual reports + 8 quarterly reports — the Q1 truth dump continues
The April 10-K filing season is still at peak density. Thursday adds 25 more full-year audited financials to the stack, alongside 8 quarterly reports. Combined with Wednesday's 109 10-Ks and 3 10-Qs, the market has processed over 145 audited annual statements in two days. Every one contains a cash flow statement. Every one reveals whether a company's reported profits are backed by real cash — the "Cash Flow Shield" that has been the dominant analytical framework throughout this month's tape.
25
10-K Annual
8
10-Q Quarterly
95
8-K Events
Week's Bottom Line — Apr 13–16
Systematic Exits. Surgical Buys. A Market of Cash Flow Kings vs. Everyone Else.
Four sessions in. The week's pattern is consistent: insiders are reducing broad exposure (banking, industrial tech, consumer discretionary, satellite, logistics) while making highly selective buys in rate-immune names — food staples, specialized healthcare, B2B payments. The buyers aren't buying the dip broadly. They're finding specific businesses where cash generation is structurally protected from the macro environment. That selection discipline, sustained across four consecutive sessions, is the most important signal of the week.
← Previous Session
Wednesday Apr 15 — $12.1B & The 109 10-K Truth Dump 🐋📊
→
6.5 Sellers for Every Buyer.
The Form 4s Don't Lie.
Insiders are systematically exiting into current liquidity. InsiderPopup shows you every move the moment it hits the SEC — so you're reading the same tape the smart money is writing.
🍎 Download InsiderPopup FreeDisclaimer: This report is for informational and educational purposes only and does not constitute financial, investment, or legal advice. Insider trading data represents historical filings and is not predictive of future stock performance. We do not guarantee the accuracy or completeness of the data provided. You should conduct your own due diligence. The author and InsiderPopup are not responsible for any financial losses.